Antiviral treatment for HCV recurrence after liver transplantation: when, how much and for how long?

Author： De Martin Eleonora   Rodriguez-Castro Kryssia I   Vitale Alessandro   Zanus Giacomo   Senzolo Marco   Russo Francesco Paolo   Burra Patrizia  

Publisher： Future Medicine

ISSN： 1746-0794

Source： Future Virology, Vol.6, Iss.10, 2011-10, pp. : 1179-1186

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Imatinib Dosing in Gastrointestinal Stromal Tumors (GISTs): When, How Much, and How Long?

By  

Current Clinical Pharmacology, Vol. 10, Iss. 4, 2015-10 ,pp. : 311-320

Bentham Science Publishers

Access to resources Recommend Favorite

HCV screening and treatment vs liver transplantation

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 329, 2001-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Digoxin-Specific Antibody Fragments: How Much and When?

By Bateman D. Nicholas  

Adverse Drug Reactions & Toxicological Reviews (now known as Toxicological Reviews), Vol. 23, Iss. 3, 2004-01 ,pp. : 135-143

Adis International

Access to resources Recommend Favorite

How Much Is Too Much?

By COLEMAN WILLIAM P.  

Dermatologic Surgery, Vol. 22, Iss. 11, 1996-11 ,pp. : 978-978

Elsevier

Access to resources Recommend Favorite

Assessment of health‐related quality of life in Egyptian HCV‐infected recipients after living donor liver transplantation

By  

Journal of Digestive Diseases, Vol. 16, Iss. 11, 2015-11 ,pp. : 675-682

John Wiley & Sons Inc

Access to resources Recommend Favorite